Zacks: Brokerages Set $22.00 Target Price for IntriCon Co. (IIN)

IntriCon Co. (NASDAQ:IIN) has earned an average broker rating score of 2.50 (Hold) from the two brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and one has assigned a buy recommendation to the company.

Brokers have set a 12 month consensus price objective of $22.00 for the company and are anticipating that the company will post $0.06 earnings per share for the current quarter, according to Zacks. Zacks has also given IntriCon an industry rank of 142 out of 265 based on the ratings given to related companies.

How to Become a New Pot Stock Millionaire

Several research firms have weighed in on IIN. Zacks Investment Research upgraded shares of IntriCon from a “hold” rating to a “strong-buy” rating and set a $23.00 price objective on the stock in a research report on Wednesday, January 3rd. TheStreet upgraded shares of IntriCon from a “c” rating to a “b-” rating in a research report on Wednesday, November 8th.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC grew its position in IntriCon by 21.5% during the 4th quarter. Renaissance Technologies LLC now owns 288,600 shares of the technology company’s stock worth $5,714,000 after purchasing an additional 51,000 shares in the last quarter. EAM Investors LLC grew its holdings in shares of IntriCon by 185.6% during the 4th quarter. EAM Investors LLC now owns 138,873 shares of the technology company’s stock valued at $2,750,000 after acquiring an additional 90,253 shares in the last quarter. Algert Global LLC grew its holdings in shares of IntriCon by 165.7% during the 4th quarter. Algert Global LLC now owns 87,059 shares of the technology company’s stock valued at $1,724,000 after acquiring an additional 54,299 shares in the last quarter. Deutsche Bank AG grew its holdings in shares of IntriCon by 43.3% during the 4th quarter. Deutsche Bank AG now owns 62,602 shares of the technology company’s stock valued at $1,239,000 after acquiring an additional 18,910 shares in the last quarter. Finally, Essex Investment Management Co. LLC purchased a new position in shares of IntriCon during the 3rd quarter valued at $267,000. Hedge funds and other institutional investors own 37.69% of the company’s stock.

IntriCon (IIN) traded down $0.35 during trading on Wednesday, reaching $18.05. 122,686 shares of the company’s stock traded hands, compared to its average volume of 84,382. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.54 and a current ratio of 1.45. The firm has a market capitalization of $126.96, a price-to-earnings ratio of 75.21, a price-to-earnings-growth ratio of 1.98 and a beta of 0.16. IntriCon has a 12-month low of $6.05 and a 12-month high of $24.00.

IntriCon (NASDAQ:IIN) last posted its quarterly earnings results on Monday, February 12th. The technology company reported $0.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.01. The firm had revenue of $22.23 million for the quarter. IntriCon had a net margin of 2.04% and a return on equity of 10.82%. analysts predict that IntriCon will post 0.62 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Set $22.00 Target Price for IntriCon Co. (IIN)” was originally published by BBNS and is owned by of BBNS. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://baseballnewssource.com/2018/03/30/zacks-brokerages-set-22-00-target-price-for-intricon-co-iin/1974646.html.

About IntriCon

IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.

Get a free copy of the Zacks research report on IntriCon (IIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL
Ohtani Goes Deep in Third Straight Game for Angels
Ohtani Goes Deep in Third Straight Game for Angels
Charlie Blackmon Agrees to Contract Extension with Colorado Rockies
Charlie Blackmon Agrees to Contract Extension with Colorado Rockies


Leave a Reply

 
© 2006-2018 BBNS.